- Primary Antibodies
-
ELISA Kits
- Infectious Disease ELISA Kits
- Parasitology ELISA kits
- Normalization ELISA Kits
- Kidney Injury Biomarker ELISA Kits
- Human ELISA Kits
- Rat ELISA Kits
- Mouse ELISA Kits
- Bovine ELISA Kits
- Porcine Protein ELISA Kits
- Chicken Protein ELISA Kits
- Dog/Canine ELISA Kits
- Small Molecules ELISA Kits
- Monkey & other ELISA Kits
- Food ELISA Kits
- Autoimmune Disease ELISA Kits
- Cancer Biomarker ELISA Kits
- Steroids ELISA Kits
-
Proteins
- Recombinant Proteins
- Growth Factors
- Cancer
- Cardiology
- Cell structure protein
- Developmental Biology
- DNA/RNA Emyzme
- Endocrinology
- Epigenetic erasers
- Epigenetic readers
- Epigenetic writers
- Extracellular Matrix
- Gastrointestinal Diseases
- Glycobiology
- Haemetology
- Hematology
- Immunology
- Infectious disease
- Inflammation
- Metabolism
- Motorsystem
- Neuroscience
- Other
- Proteases
- Signaling Pathway
- Transcription Factor
- Ubiquitin
- Urology
- CRISPR/Cas9 Protein
- Peptides
- Reagents
-
Services
- Recombinant protein expression and purification (NB-SC101)
- Antibody Services (NB-SC102)
- ELISA Assay Development (NB-SC103)
- Antibody Pair Screening (NB-SC104)
- AlphaLisa™ and Alphascreen™ Assays (NB-SC105)
- Hybridoma Sequencing (NB-SC106)
- Development of an AlphaLisa assay for Screening Histone Methyltransferase Inhibitors (NB-SC107)
- Ultrasensitive ELISA/ ImmunoPCR (NB-SC108)
- Generation of Stable Cell Lines Expressing Antibodies (NB-SC109)
- Antibody Sequencing/ Recombinant Antibody Production (NB-SC110)
- Antibody Conjugation Services (NB-SC111)
- ELISA Testing services (NB-SC112)
- Western Blot Service (NB-SC113)
- Protocols
-
News
-
News
- Novatein Biosciences Introduces the Human Anti-Carbamylated Protein Antibody (Anti-CarP) ELISA Kit
- Launch of immunoPCR assay development and antibody-DNA conjugation services
- Novatein Biosciences launched antigen and antibodies products for the 2019-nCoV/COVIS-19/SARS-COV2 research.
- NovaTeinBio Introduce Hundreds of New ELISA Kit Products Through Their Company Catalogue
- NovaTeinBio Advancing Research with New CD Antigen Solutions
- NovaTeinBio Adds New Antibodies to Company Catalogue
- NovaTeinBio Add Protein Expression and Purification to Their Service Catalogue
- NovaTeinBio Announces Discount on New Human PEG 20000 ELISA Kit
- Food ELISA kits
- NovaTeinBio Now Offering Wider Range of ELISA Kit Testing Solutions
- Cancer Biomarker ELISA kits
- Reliable Detection of CRISPR Activity Using Cas9 Monoclonal Antibodies
- How Do Cas9 Monoclonal Antibodies Improve CRISPR Validation Accuracy?
- Why ELISA Kits Are Essential for Steroid Testing in Clinical Studies
- How to Optimize Your Workflow Using the Human CEA ELISA Kit
- Why Penicillin ELISA Kits Are Critical in Dairy Product Screening
- How Human CD161 Antibody Research Advances Immunology Insights
- OVA sIgG ELISA Kits: Measuring Immune Response Made Simple
- Why Gluten ELISA Testing Is Crucial for Celiac-Safe Products
- Why Penicillin ELISA Testing Remains Critical in Food Safety Programs
- Quantifying Human Lipoproteins in Serum Using ELISA Technology
- What Is CBX3 Antibody Used For in Epigenetics Studies?
- Canine beta NGF ELISA Kit 96T: Accurate Detection for Veterinary Research
- What's Porcine Luteinizing Hormone and How's It Used
- Best Practices for Using a CRISPR/Cas9 Host Autoantibody ELISA Kit
- How to Choose the Right Human Ovalbumin IgG ELISA Kit
- How CD161 Antibodies Help Study Immune Cell Populations
- Novatein Biosciences Launches Redesigned Website to Enhance Access to Life Science Research Products and Services
- News Letters
- Product Citations
-
News
- Distributors
-
Support
Human Uteroglobin ELISA Kit
Catalog # NR-E10440
Assay Range | 156 - 10,000 pg/mL |
Sensitivity | 10.0 pg/mL |
Size | 96T |
Storage | Store at 2 - 8ºC. Keep reconstituted standard and detection Ab at -20 ºC |
Assay Principle | Sandwich ELISA |
Sample volume | 100 µL final volume, dilution factor varies on samples. |
Detection Method | Chromogenic |
Kit Components
1. Recombinant Human Uteroglobin standard: 2 vials.
2. One 96-well plate precoated with anti- Human Uteroglobin Ab
3. Sample diluent buffer: 12 mL - 1
4. Detection antibody: 130 µL, dilution 1:100.
5. Streptavidin-HRP: 130 µL, dilution 1:100
6. Antibody diluent buffer: 12 mL x1
7. Streptavidin-HRP diluent buffer: 12 mL x1
8. TMB developing agent: 10 mL x1
9. Stop solution: 10 mL x1.
10. Washing solution (20x): 25 mL x1.
Background
Uteroglobin, also known as Clara cell phospholipid-binding protein (CCPBP), Clara cells 10 kDa secretory protein (CC10), Secretoglobin family 1A member 1, Urinary protein 1 (UP-1), is a small, non-glycosylated secreted protein of the secretoglobin superfamily. Mature human Uteroglobin is a 70 amino acid (aa) protein produced by the non-ciliated, non-mucous, secretory cells that predominate in lung bronchioles (Clara cells) and other non-ciliated epithelia and has been observed in blood, urine, and other body fluids. Expression of Uteroglobin is induced by steroid hormones such as estrogen and by the non-steroid hormone prolactin.
Uteroglobin exists as a disulfide-linked head-to-tail homodimer in which the binding pocket may contribute to binding of hydrophobic ligands such as phospholipids, progesterone, and retinols. Uteroglobin affects many aspects of immunoregulation. It sequesters prostaglandins and leukotrienes, limiting their inflammatory effects, while also inhibiting the activity of phospholipase A2, an enzyme in their synthesis pathway. It can inhibit dendritic cell migration by binding the chemotaxis-related formyl peptide receptor, FPR2. Mice deficient in Uteroglobin show exaggerated response to allergens and pollutants. Since most circulating Uteroglobin is produced by lung Clara cells, low plasma Uteroglobin is an indicator of low Clara cell production that is typical of airway injury. Uteroglobin also is a ligand for some transmembrane or extracellular matrix molecules. For example, it can bind the adhesion molecule fibronectin and may be crosslinked to fibronectin by another ligand, transglutaminase. Uteroglobin is a potent inhibitor of thrombin-induced platelet aggregation. It is reported that binding of Uteroglobin to the lipocalin-1 receptor (LRBM1L) is capable of suppressing motility of cancer cells.